ELAB (Elevai Labs Inc) Net Profit

ELAB (elevaiskincare.com) - company brandmark

Elevai Labs Inc. (ELAB) creates innovative exosome-based products for dermatologists and aestheticians. The company's profit dynamics reflect market volatility, while -0.01 represents the latest level value. The strategy is based on integrating precision tissue rejuvenation into cosmetology. However, at the start of sales, aggressive marketing is increasing costs, which temporarily limits the operational efficiency of the biotech business.

ELAB (Elevai Labs Inc.) Company Net Income history from 02/21/2024 to 10/31/2026

Financial and market metric breakdowns for Elevai Labs (ELAB)

- price and consensus price forecast:
Stock Quotes Elevai Corp|ELAB - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Elevai Corp|ELAB - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Elevai Labs|ELAB - Company Book Value|Market Capitalization to Book Value elevaiskincare.com|ELAB - Aggregate Company Assets
- debt and solvency information:
Total Debt to Capital Elevai Labs Inc.|ELAB - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Elevai Labs Inc|ELAB - Company Debts|Debt to Book Value Ratio Elevai Corp|ELAB - Company Long-Term Debts|Short-Term Debt Elevai Labs|Quick Liquidity elevaiskincare.com
- net income and valuation multiples indicators:
ELAB - Net Profit
Basic company analysis:Elevai Corp
Manufactured product of Elevai Skincare

To identify the fundamental drivers of stability for Elevai Labs Inc. (ELAB), examine the company's financial profit, which reflects the daily cumulative net income for the current trading period. This metric consolidates total revenue minus all expenses, illustrating on the chart the monetization efficiency of patented rejuvenation technologies and the demand from affluent clients for innovative stem cell-based cosmetics.

Direct competitors

Net Income Krystal Biotech Corp.|APGE (Apogee Therapeutics) - Net Profit|Net Profit arcutis.com|Net Income VCEL (Vericel)|ORKA (Oruka Therapeutics, Inc.) - Final Profit|Company Net Income Sanara MedTech SMTI|Net Financial Result DBV Tech (DBVT)|SLSN - Company Net Income|DERM - Net Profit|FBRX: Net Profit|EMPG - Net Financial Result|Company Net Income Sol-Gel|Company Profit AXIL (Revive Pro Care)|Net Profit MDCX|VRCA - Company Net Income|Company Net Income Hoth Therapeutics HOTH|Biofrontera, Inc. - Company Net Income|VYNE Therapeutics Inc - Net Profit|Company Net Income Sonoma Pharmaceuticals|QNRX (quoinpharma.com) - Net Income|AZTR (azitrainc.com) - Company Net Income|DRMA (Dermata Therapeutics, Inc.) - Net Profit|Net Profit Revance Therapeutics Inc.